![Rod Adams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rod Adams
Vorsitzender bei Neotherix Ltd.
Ursprung des Netzwerks ersten Grades von Rod Adams
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Other | 5 | |
Neotherix Ltd.
![]() Neotherix Ltd. Medical SpecialtiesHealth Technology Neotherix Ltd. is a British company that specializes in soft tissue repair using the body's natural healing abilities. Neotherix is based in York, UK and was founded in 2007 by Mike Raxworthy, who has been the CEO since then. The private company has developed innovative solutions for wound repair using electrospun scaffolds and phototherix™ technology that reduces the need for antibiotics. The company's seton scaffold device™ (ssd) is used to support ongoing active seton drainage and tissue regrowth. The company's ektotherix™ technology uses electrospun fibers for cell attachment and movement into the wound space to successfully heal wounds with minimal scarring.
1
| Private Company | Medical Specialties | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rod Adams
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Tudor Investment Corp.
![]() Tudor Investment Corp. Investment ManagersFinance Tudor Investment Corp. (TIC) is an independent, SEC-registered investment adviser and hedge fund manager headquartered in Stamford, Connecticut. The firm was founded in 1980 by Paul T. Jones, II. TIC provides discretionary investment advisory services to various hedge funds, private equity funds and managed accounts. Investors in these funds generally include high-net worth individuals and related entities, sovereign entities, pension funds, non-financial corporates, financial institutions, endowments and foundations, fund-of-fund vehicles and proprietary capital from current and former personnel. | Investment Managers | Portfolio Manager-Equities | |
Reckitt Benckiser Healthcare International Ltd.
![]() Reckitt Benckiser Healthcare International Ltd. Household/Personal CareConsumer Non-Durables Reckitt Benckiser Healthcare International Ltd. manufactures healthcare and beauty products. The company develops & markets analgesics, upper respiratory tract and skincare products. It is headquartered in Nottingham, the United Kingdom. | Household/Personal Care | Chief Tech/Sci/R&D Officer | |
Tudor Capital Europe LLP
![]() Tudor Capital Europe LLP Investment ManagersFinance Tudor Capital Europe LLP is an alternative investment manager headquartered in London, UK. The firm was founded in 1995 and is a subsidiary of Tudor Overseas Holdings LLC, which is owned by Tudor Investment Corp. in the US. Tudor Capital Europe manages assets across fixed income, currency, equity and commodity asset classes and related derivative instruments in the global markets for an international clientele. | Investment Managers | Portfolio Manager-Equities | |
Nektar Therapeutics UK Ltd.
![]() Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Pharmaceuticals: Major | Founder | |
Glaxo SmithKline Consumer Healthcare Ltd.
![]() Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services GlaxoSmithKline Consumer Healthcare manufactures and supplies over the counter drugs. It focuses on oral healthcare, over the counter medicines and nutritional healthcare products. Its brands and products include oral care (Aquafresh) to dermatology (Zovirax), with all kinds of analgesics (Panadol), gastrointestinal remedies (Tums) and smoking-cessation products (Nicoderm). The company is headquartered in Brentford, UK | Medical Distributors | Director/Board Member | |
AVACTA GROUP PLC | Miscellaneous Commercial Services | Chairman | |
Zilico Ltd.
![]() Zilico Ltd. BiotechnologyHealth Technology Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom. | Biotechnology | Director/Board Member | |
Queens' College Cambridge | College/University | Graduate Degree | |
SolAeroMed, Inc.
![]() SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Proveca Ltd.
![]() Proveca Ltd. Pharmaceuticals: MajorHealth Technology Proveca Ltd. develops pharmaceuticals for children and adults through studies dedicated to providing evidence for the specific use of off-patent medicines. The firm develops medicines for children in the fields of cardiology, neurology, and pain management. The company was founded by Simon Peter Bryson and Helen Margaret Shaw in July 2010 and is headquartered in Warrington, the United Kingdom. | Pharmaceuticals: Major | Founder | |
NuVision Biotherapies Ltd.
![]() NuVision Biotherapies Ltd. Pharmaceuticals: MajorHealth Technology NuVision Biotherapies Ltd. commercializes biotherapies for treating ‘front of the eye’ disease and trauma. It offers Omnigen, an ‘off the shelf’, transportable biological matrix that can be used as an effective wound dressing for a range of indications including ocular surface indications. The firm also offers Tereo, a process that gently preserves the tissue such that it is stored in a dry state. The company was founded by Andrew Hopkinson in July 2014 and is headquartered in Nottingham, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Veriton Pharma Ltd.
![]() Veriton Pharma Ltd. Pharmaceuticals: MajorHealth Technology Veriton Pharma Ltd. engages in the development and manufacture of pharmaceutical products which focuses in the fields of epilepsy, neurology and rare paediatric conditions. It offers Epistatus, paediatric medicine, and inborn errors of metabolism medicine. The company was founded by Graham March in 1997 and is headquartered in Weybridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
Vereinigtes Königreich | 13 |
Vereinigte Staaten | 2 |
Australien | 2 |
Kanada | 2 |
Sektoral
Health Technology | 7 |
Finance | 4 |
Consumer Non-Durables | 2 |
Distribution Services | 2 |
Commercial Services | 2 |
Operativ
Director/Board Member | 11 |
Founder | 4 |
Chairman | 3 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 3 |